デフォルト表紙
市場調査レポート
商品コード
1493177

臨床意思決定支援システムの市場規模、シェア、動向分析レポート:製品別、用途別、提供形態別、コンポーネント別、地域別、セグメント予測、2024年~2030年

Clinical Decision Support Systems Market Size, Share & Trends Analysis Report By Product (Standalone CDSS, Integrated EHR With CDSS), By Application (Drug-Drug Interactions), By Delivery Mode, By Component, By Region, And Segment Forecasts, 2024 - 2030


出版日
ページ情報
英文 135 Pages
納期
2~10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.82円
臨床意思決定支援システムの市場規模、シェア、動向分析レポート:製品別、用途別、提供形態別、コンポーネント別、地域別、セグメント予測、2024年~2030年
出版日: 2024年05月02日
発行: Grand View Research
ページ情報: 英文 135 Pages
納期: 2~10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

臨床意思決定支援システム市場の成長と動向:

Grand View Research, Inc.の最新レポートによると、臨床意思決定支援システムの世界市場規模は2030年までに107億1,000万米ドルに達すると予測され、2024年から2030年までのCAGRは10.79%で成長すると予測されています。

臨床意思決定支援システム(CDSS)の導入と統合を促進することを目的とした政府のイニシアチブは、病院や医療機関にそのようなソリューションを導入するインセンティブを与えることにより、市場の成長を促進すると予想されます。例えば、米国保健福祉省(HHS)は2023年4月、臨床意思決定支援ツールの利用拡大を奨励するため、認証プログラムの規則を改定しました。さらに、AIとクラウドベースのCDSS技術の進歩が市場拡大を加速すると予測されます。CDSSプラットフォームとデータベース管理を強化するためのクラウドベースのコンピューティングの導入も、予測期間における市場成長にプラスの影響を与えると予測されています。

COVID-19パンデミックの間、様々な政府機関や地域団体がヘルスケアインフラを強化するための取り組みを開始しました。これらの取り組みは、州当局による最前線の診療所の設置から、医療専門家のボランティアパネルの動員、民間の遠隔医療プラットフォームの展開まで多岐にわたった。臨床判断支援システム(CDSS)は、この危機的状況において、医師が診療の時点で十分な情報に基づいた判断を下せるよう支援し、必要不可欠であることを証明しました。

その結果、市場参入企業はこの機会を活用して課題に対処し、最前線の医療提供者を支援しました。例えば、2022年5月、athenahealth, Inc.の子会社であるepocratesは、COVID-19パンデミックによってもたらされた課題をよりよく管理するために、臨床意思決定支援ツールを強化しました。

さらに、複数の企業が臨床意思決定支援システム(CDSS)の提供を強化する戦略を積極的に実施し、市場での地位を固めています。例えば、2024年2月、Elsevier Healthは、医療領域向けにカスタマイズされたAIソリューションの著名なプロバイダーであるOpenEvidenceと協業し、米国でClinicalKey AIを発売しました。この協業では、高度な医療コンテンツと生成型人工知能(AI)を統合し、臨床医による患者ケアのやり取りを支援します。

臨床意思決定支援システム市場レポートハイライト

  • 製品別では、スタンドアロン型CDSSセグメントが、その低コストに起因して、2023年に30.85%の最大収益シェアで市場をリードしました。同セグメントは2030年までに市場全体の約31.0%を占めると推定されます。
  • 用途別では、アレルギーの負担が増加していることから、薬物アレルギー警報分野が2023年に25.83%の最大収益シェアで市場をリードしました。
  • 提供形態別では、オンプレミス部門が2023年に42.35%の最大収益シェアで市場をリードしました。
  • コンポーネント別では、サービス分野が2023年に42.49%の最大売上シェアで市場をリードしました。
  • 北米が2023年に43.76%の収益シェアで市場を独占しました。これは、市場プレイヤーの強い存在感と、臨床意思決定支援ツールの効率的な利用を促進するための政府の取り組みが増加しているためです。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 臨床意思決定支援システム市場の変数、動向、範囲

  • 市場系統の見通し
    • 親市場の見通し
    • 関連/付随市場の見通し
  • 市場力学
    • 市場 促進要因分析
    • 市場抑制要因分析
  • 臨床意思決定支援システム市場分析ツール
    • 業界分析- ポーターのファイブフォース分析
    • PESTEL分析
  • COVID-19の影響

第4章 臨床意思決定支援システム市場:製品の推定・動向分析

  • 製品市場シェア、2023年および2030年
  • セグメントダッシュボード
  • 世界臨床意思決定支援システム市場、製品別展望
  • スタンドアロンCDSS
  • CDSSと統合したCPOE
  • CDSSと統合したEHR
  • CPOEとHERを統合したCDSS

第5章 臨床意思決定支援システム市場:用途の推定・動向分析

  • 用途市場シェア、2023年および2030年
  • セグメントダッシュボード
  • 世界の臨床意思決定支援システム市場、用途別展望
  • 薬物相互作用
  • 薬物アレルギー警告
  • 臨床上の注意
  • 臨床ガイドライン
  • 薬剤投与サポート
  • その他

第6章 臨床意思決定支援システム市場:提供モードの推定・動向分析

  • 提供モードの市場シェア、2023年と2030年
  • セグメントダッシュボード
  • 世界の臨床意思決定支援システム市場、提供モード別展望
  • Webベースのシステム
  • クラウドベースのシステム
  • オンプレミスシステム

第7章 臨床意思決定支援システム市場:コンポーネントの推定・動向分析

  • コンポーネント市場シェア、2023年および2030年
  • セグメントダッシュボード
  • 世界の臨床意思決定支援システム市場、コンポーネント別展望
  • ハードウェア
  • ソフトウェア
  • サービス

第8章 臨床意思決定支援システム市場:地域推定・動向分析、タイプ別、用途別、提供モード別、コンポーネント別

  • 地域別市場シェア分析、2023年および2030年
  • 地域市場ダッシュボード
  • 世界地域市場スナップショット
  • 市場規模と予測トレンド分析、2018年から2030年
  • 北米
  • 欧州
  • アジア太平洋地域
  • ラテンアメリカ
  • 中東・アフリカ

第9章 競合情勢

  • 主要市場参入企業による最近の動向と影響分析
  • 企業/競合の分類
    • イノベーター
  • ベンダー情勢
    • 主要ディストリビューターおよびチャネルパートナーのリスト
    • 主要顧客
    • 主要企業の市場シェア分析、2023年
    • McKesson Corporation
    • Oracle(Cerner Corporation)
    • Siemens Healthineers GmbH
    • Allscripts Healthcare, LLC
    • athenahealth, Inc.
    • NextGen Healthcare Inc.
    • Koninklijke Philips NV
    • IBM
    • Agfa-Gevaert Group
    • Wolters Kluwer NV
図表

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 North America clinical decision support systems market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 4 North America clinical decision support systems market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 5 North America clinical decision support systems market estimates and forecasts, by delivery mode, 2018 - 2030 (USD Million)
  • Table 6 North America clinical decision support systems market estimates and forecasts, by component, 2018 - 2030 (USD Million)
  • Table 7 U.S. clinical decision support systems market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 8 U.S. clinical decision support systems market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 9 U.S. clinical decision support systems market estimates and forecasts, by delivery mode, 2018 - 2030 (USD Million)
  • Table 10 U.S. clinical decision support systems market estimates and forecasts, by component, 2018 - 2030 (USD Million)
  • Table 11 Canada clinical decision support systems market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 12 Canada clinical decision support systems market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 13 Canada clinical decision support systems market estimates and forecasts, by delivery mode, 2018 - 2030 (USD Million)
  • Table 14 Canada clinical decision support systems market estimates and forecasts, by component, 2018 - 2030 (USD Million)
  • Table 15 Europe clinical decision support systems market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 16 Europe clinical decision support systems market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 17 Europe clinical decision support systems market estimates and forecasts, by delivery mode, 2018 - 2030 (USD Million)
  • Table 18 Europe clinical decision support systems market estimates and forecasts, by component, 2018 - 2030 (USD Million)
  • Table 19 UK clinical decision support systems market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 20 UK clinical decision support systems market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 21 UK clinical decision support systems market estimates and forecasts, by delivery mode, 2018 - 2030 (USD Million)
  • Table 22 UK clinical decision support systems market estimates and forecasts, by component, 2018 - 2030 (USD Million)
  • Table 23 Germany clinical decision support systems market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 24 Germany clinical decision support systems market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 25 Germany clinical decision support systems market estimates and forecasts, by delivery mode, 2018 - 2030 (USD Million)
  • Table 26 Germany clinical decision support systems market estimates and forecasts, by component, 2018 - 2030 (USD Million)
  • Table 27 France clinical decision support systems market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 28 France clinical decision support systems market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 29 France clinical decision support systems market estimates and forecasts, by delivery mode, 2018 - 2030 (USD Million)
  • Table 30 France clinical decision support systems market estimates and forecasts, by component, 2018 - 2030 (USD Million)
  • Table 31 Italy clinical decision support systems market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 32 Italy clinical decision support systems market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 33 Italy clinical decision support systems market estimates and forecasts, by delivery mode, 2018 - 2030 (USD Million)
  • Table 34 Italy clinical decision support systems market estimates and forecasts, by component, 2018 - 2030 (USD Million)
  • Table 35 Spain clinical decision support systems market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 36 Spain clinical decision support systems market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 37 Spain clinical decision support systems market estimates and forecasts, by delivery mode, 2018 - 2030 (USD Million)
  • Table 38 Spain clinical decision support systems market estimates and forecasts, by component, 2018 - 2030 (USD Million)
  • Table 39 Sweden clinical decision support systems market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 40 Sweden clinical decision support systems market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 41 Sweden clinical decision support systems market estimates and forecasts, by delivery mode, 2018 - 2030 (USD Million)
  • Table 42 Sweden clinical decision support systems market estimates and forecasts, by component, 2018 - 2030 (USD Million)
  • Table 43 Denmark clinical decision support systems market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 44 Denmark clinical decision support systems market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 45 Denmark clinical decision support systems market estimates and forecasts, by delivery mode, 2018 - 2030 (USD Million)
  • Table 46 Denmark clinical decision support systems market estimates and forecasts, by component, 2018 - 2030 (USD Million)
  • Table 47 Norway clinical decision support systems market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 48 Norway clinical decision support systems market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 49 Norway clinical decision support systems market estimates and forecasts, by delivery mode, 2018 - 2030 (USD Million)
  • Table 50 Norway clinical decision support systems market estimates and forecasts, by component, 2018 - 2030 (USD Million)
  • Table 51 Asia Pacific clinical decision support systems market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 52 Asia Pacific clinical decision support systems market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 53 Asia Pacific clinical decision support systems market estimates and forecasts, by delivery mode, 2018 - 2030 (USD Million)
  • Table 54 Asia Pacific clinical decision support systems market estimates and forecasts, by component, 2018 - 2030 (USD Million)
  • Table 55 Japan clinical decision support systems market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 56 Japan clinical decision support systems market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 57 Japan clinical decision support systems market estimates and forecasts, by delivery mode, 2018 - 2030 (USD Million)
  • Table 58 Japan clinical decision support systems market estimates and forecasts, by component, 2018 - 2030 (USD Million)
  • Table 59 China clinical decision support systems market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 60 China clinical decision support systems market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 61 China clinical decision support systems market estimates and forecasts, by delivery mode, 2018 - 2030 (USD Million)
  • Table 62 China clinical decision support systems market estimates and forecasts, by component, 2018 - 2030 (USD Million)
  • Table 63 India clinical decision support systems market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 64 India clinical decision support systems market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 65 India clinical decision support systems market estimates and forecasts, by delivery mode, 2018 - 2030 (USD Million)
  • Table 66 India clinical decision support systems market estimates and forecasts, by component, 2018 - 2030 (USD Million)
  • Table 67 Australia clinical decision support systems market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 68 Australia clinical decision support systems market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 69 Australia clinical decision support systems market estimates and forecasts, by delivery mode, 2018 - 2030 (USD Million)
  • Table 70 Australia clinical decision support systems market estimates and forecasts, by component, 2018 - 2030 (USD Million)
  • Table 71 South Korea clinical decision support systems market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 72 South Korea clinical decision support systems market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 73 South Korea clinical decision support systems market estimates and forecasts, by delivery mode, 2018 - 2030 (USD Million)
  • Table 74 South Korea clinical decision support systems market estimates and forecasts, by component, 2018 - 2030 (USD Million)
  • Table 75 Thailand clinical decision support systems market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 76 Thailand clinical decision support systems market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 77 Thailand clinical decision support systems market estimates and forecasts, by delivery mode, 2018 - 2030 (USD Million)
  • Table 78 Thailand clinical decision support systems market estimates and forecasts, by component, 2018 - 2030 (USD Million)
  • Table 79 Latin America clinical decision support systems market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 80 Latin America clinical decision support systems market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 81 Latin America clinical decision support systems market estimates and forecasts, by delivery mode, 2018 - 2030 (USD Million)
  • Table 82 Latin America clinical decision support systems market estimates and forecasts, by component, 2018 - 2030 (USD Million)
  • Table 83 Brazil clinical decision support systems market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 84 Brazil clinical decision support systems market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 85 Brazil clinical decision support systems market estimates and forecasts, by delivery mode, 2018 - 2030 (USD Million)
  • Table 86 Brazil clinical decision support systems market estimates and forecasts, by component, 2018 - 2030 (USD Million)
  • Table 87 Mexico clinical decision support systems market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 88 Mexico clinical decision support systems market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 89 Mexico clinical decision support systems market estimates and forecasts, by delivery mode, 2018 - 2030 (USD Million)
  • Table 90 Mexico clinical decision support systems market estimates and forecasts, by component, 2018 - 2030 (USD Million)
  • Table 91 Argentina clinical decision support systems market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 92 Argentina clinical decision support systems market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 93 Argentina clinical decision support systems market estimates and forecasts, by delivery mode, 2018 - 2030 (USD Million)
  • Table 94 Argentina clinical decision support systems market estimates and forecasts, by component, 2018 - 2030 (USD Million)
  • Table 95 MEA clinical decision support systems market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 96 MEA clinical decision support systems market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 97 MEA clinical decision support systems market estimates and forecasts, by delivery mode, 2018 - 2030 (USD Million)
  • Table 98 MEA clinical decision support systems market estimates and forecasts, by component, 2018 - 2030 (USD Million)
  • Table 99 South Africa clinical decision support systems market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 100 South Africa clinical decision support systems market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 101 South Africa clinical decision support systems market estimates and forecasts, by delivery mode, 2018 - 2030 (USD Million)
  • Table 102 South Africa clinical decision support systems market estimates and forecasts, by component, 2018 - 2030 (USD Million)
  • Table 103 Saudi Arabia clinical decision support systems market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 104 Saudi Arabia clinical decision support systems market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 105 Saudi Arabia clinical decision support systems market estimates and forecasts, by delivery mode, 2018 - 2030 (USD Million)
  • Table 106 Saudi Arabia clinical decision support systems market estimates and forecasts, by component, 2018 - 2030 (USD Million)
  • Table 107 UAE clinical decision support systems market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 108 UAE clinical decision support systems market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 109 UAE clinical decision support systems market estimates and forecasts, by delivery mode, 2018 - 2030 (USD Million)
  • Table 110 UAE clinical decision support systems market estimates and forecasts, by component, 2018 - 2030 (USD Million)
  • Table 111 Kuwait clinical decision support systems market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 112 Kuwait clinical decision support systems market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 113 Kuwait clinical decision support systems market estimates and forecasts, by delivery mode, 2018 - 2030 (USD Million)
  • Table 114 Kuwait clinical decision support systems market estimates and forecasts, by component, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Clinical decision support systems market: market outlook
  • Fig. 9 Clinical decision support systems competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Industry value chain analysis
  • Fig. 14 Clinical decision support systems market driver impact
  • Fig. 15 Clinical decision support systems market restraint impact
  • Fig. 16 Clinical decision support systems market strategic initiatives analysis
  • Fig. 17 Clinical decision support systems market: Type movement analysis
  • Fig. 18 Clinical decision support systems market: Type outlook and key takeaways
  • Fig. 19 Standalone CDSS market estimates and forecast, 2018 - 2030
  • Fig. 20 Integrated CPOE with CDSS market estimates and forecast, 2018 - 2030
  • Fig. 21 Integrated EHR with CDSS market estimates and forecast, 2018 - 2030
  • Fig. 22 Integrated CDSS with CPOE and EHR market estimates and forecast, 2018 - 2030
  • Fig. 23 Clinical decision support systems market: Application movement analysis
  • Fig. 24 Clinical decision support systems market: Application outlook and key takeaways
  • Fig. 25 Drug-drug interactions market estimates and forecast, 2018 - 2030
  • Fig. 26 Drug allergy alerts market estimates and forecast, 2018 - 2030
  • Fig. 27 Clinical reminders market estimates and forecast, 2018 - 2030
  • Fig. 28 Clinical guidelines market estimates and forecast, 2018 - 2030
  • Fig. 29 Drug dosing support market estimates and forecast, 2018 - 2030
  • Fig. 30 Others market estimates and forecast, 2018 - 2030
  • Fig. 31 Clinical decision support systems market: Delivery Mode movement analysis
  • Fig. 32 Clinical decision support systems market: Delivery Mode outlook and key takeaways
  • Fig. 33 Web-based systems market estimates and forecast, 2018 - 2030
  • Fig. 34 Cloud-based systems market estimates and forecast, 2018 - 2030
  • Fig. 35 On-premise systems market estimates and forecast, 2018 - 2030
  • Fig. 36 Clinical decision support systems market: Component movement analysis
  • Fig. 37 Clinical decision support systems market: Component outlook and key takeaways
  • Fig. 38 Intranasal market estimates and forecast, 2018 - 2030
  • Fig. 39 External market estimates and forecast, 2018 - 2030
  • Fig. 40 Clinical decision support systems market: End user movement analysis
  • Fig. 41 Clinical decision support systems market: End user outlook and key takeaways
  • Fig. 42 Hardware market estimates and forecast, 2018 - 2030
  • Fig. 43 Software market estimates and forecast, 2018 - 2030
  • Fig. 44 Services market estimates and forecast, 2018 - 2030
  • Fig. 45 Global clinical decision support systems market: Regional movement analysis
  • Fig. 46 Global clinical decision support systems market: Regional outlook and key takeaways
  • Fig. 47 Global clinical decision support systems market share and leading players
  • Fig. 48 North America market share and leading players
  • Fig. 49 Europe market share and leading players
  • Fig. 50 Asia Pacific market share and leading players
  • Fig. 51 Latin America market share and leading players
  • Fig. 52 Middle East & Africa market share and leading players
  • Fig. 53 North America: SWOT
  • Fig. 54 Europe SWOT
  • Fig. 55 Asia Pacific SWOT
  • Fig. 56 Latin America SWOT
  • Fig. 57 MEA SWOT
  • Fig. 58 North America
  • Fig. 59 North America market estimates and forecasts, 2018 - 2030
  • Fig. 60 US
  • Fig. 61 US market estimates and forecasts, 2018 - 2030
  • Fig. 62 Canada
  • Fig. 63 Canada market estimates and forecasts, 2018 - 2030
  • Fig. 64 Europe
  • Fig. 65 Europe market estimates and forecasts, 2018 - 2030
  • Fig. 66 UK
  • Fig. 67 UK market estimates and forecasts, 2018 - 2030
  • Fig. 68 Germany
  • Fig. 69 Germany market estimates and forecasts, 2018 - 2030
  • Fig. 70 France
  • Fig. 71 France market estimates and forecasts, 2018 - 2030
  • Fig. 72 Italy
  • Fig. 73 Italy market estimates and forecasts, 2018 - 2030
  • Fig. 74 Spain
  • Fig. 75 Spain market estimates and forecasts, 2018 - 2030
  • Fig. 76 Denmark
  • Fig. 77 Denmark market estimates and forecasts, 2018 - 2030
  • Fig. 78 Sweden
  • Fig. 79 Sweden market estimates and forecasts, 2018 - 2030
  • Fig. 80 Norway
  • Fig. 81 Norway market estimates and forecasts, 2018 - 2030
  • Fig. 82 Asia Pacific
  • Fig. 83 Asia Pacific market estimates and forecasts, 2018 - 2030
  • Fig. 84 China
  • Fig. 85 China market estimates and forecasts, 2018 - 2030
  • Fig. 86 Japan
  • Fig. 87 Japan market estimates and forecasts, 2018 - 2030
  • Fig. 88 India
  • Fig. 89 India market estimates and forecasts, 2018 - 2030
  • Fig. 90 Thailand
  • Fig. 91 Thailand market estimates and forecasts, 2018 - 2030
  • Fig. 92 South Korea
  • Fig. 93 South Korea market estimates and forecasts, 2018 - 2030
  • Fig. 94 Australia
  • Fig. 95 Australia market estimates and forecasts, 2018 - 2030
  • Fig. 96 Latin America
  • Fig. 97 Latin America market estimates and forecasts, 2018 - 2030
  • Fig. 98 Brazil
  • Fig. 99 Brazil market estimates and forecasts, 2018 - 2030
  • Fig. 100 Mexico
  • Fig. 101 Mexico market estimates and forecasts, 2018 - 2030
  • Fig. 102 Argentina
  • Fig. 103 Argentina market estimates and forecasts, 2018 - 2030
  • Fig. 104 Middle East and Africa
  • Fig. 105 Middle East and Africa market estimates and forecasts, 2018 - 2030
  • Fig. 106 South Africa
  • Fig. 107 South Africa market estimates and forecasts, 2018 - 2030
  • Fig. 108 Saudi Arabia
  • Fig. 109 Saudi Arabia market estimates and forecasts, 2018 - 2030
  • Fig. 110 UAE
  • Fig. 111 UAE market estimates and forecasts, 2018 - 2030
  • Fig. 112 Kuwait
  • Fig. 113 Kuwait market estimates and forecasts, 2018 - 2030
  • Fig. 114 Market share of key market players- Clinical decision support systems market
目次
Product Code: GVR-2-68038-339-3

Clinical Decision Support Systems Market Growth & Trends:

The global clinical decision support systems market size is anticipated to reach USD 10.71 billion by 2030 and is projected to grow at a CAGR of 10.79% from 2024 to 2030, according to a new report by Grand View Research, Inc. Government initiatives aimed at promoting the adoption and integration of Clinical Decision Support Systems (CDSS) are expected to drive market growth by incentivizing hospitals and healthcare organizations to deploy such solutions. For example, in April 2023, the U.S. Department of Health and Human Services (HHS) revised certification program rules to encourage greater utilization of clinical decision support tools. Furthermore, advancements in AI and cloud-based CDSS technologies are projected to accelerate market expansion. The implementation of cloud-based computing to enhance CDSS platforms and database management is also anticipated to positively influence market growth in the forecast period.

During the COVID-19 pandemic, various government and community organizations initiated efforts to bolster the healthcare infrastructure. These initiatives ranged from setting up frontline clinics by state authorities to mobilizing volunteer panels of medical professionals and deploying private telemedicine platforms. Clinical Decision Support Systems (CDSS) proved indispensable during this crisis, assisting physicians in making informed decisions at the point of care.

Consequently, market participants capitalized on this opportunity to address challenges and support frontline healthcare providers. For example, in May 2022, epocrates, a subsidiary of athenahealth, Inc., enhanced its clinical decision support tools to better manage the challenges posed by the COVID-19 pandemic.

Furthermore, several companies are actively implementing strategies to enhance their clinical decision support systems (CDSS) offerings, consolidating their position in the market. For example, in February 2024, Elsevier Health collaborated with OpenEvidence, a prominent provider of AI solutions customized for the medical domain, to launch ClinicalKey AI in the U.S. This collaboration involved integrating advanced medical content with generative artificial intelligence (AI) to assist clinicians in patient-care interactions.

Clinical Decision Support Systems Market Report Highlights:

  • Based on product, the standalone CDSS segment led the market with the largest revenue share of 30.85% in 2023, owing to its low cost. The segment is estimated to hold approximately 31.0% of the overall market by 2030
  • Based on application, the drug allergy alerts segment led the market with the largest revenue share of 25.83% in 2023, owing to the rising burden of allergies
  • Based on delivery mode, the on-premises segment held the market with the largest revenue share of 42.35% in 2023, owing to its high adoption rate by healthcare organizations
  • Based on component, the services segment led the market with the largest revenue share of 42.49% in 2023, owing to high frequency of updating software and other maintenance services
  • North America dominated the market with the revenue share of 43.76% in 2023, due to strong presence of market player and increasing government initiatives to promote efficient usage of clinical decision support tools

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Product
    • 1.1.2. Application
    • 1.1.3. Delivery Mode
    • 1.1.4. Component
    • 1.1.5. Regional scope
    • 1.1.6. Estimates and forecast timeline.
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
    • 1.6.2. Approach 1: Commodity flow approach
    • 1.6.3. Volume price analysis (Model 2)
    • 1.6.4. Approach 2: Volume price analysis
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Clinical Decision Support Systems Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Clinical Decision Support Systems Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic Landscape
  • 3.4. COVID-19 Impact

Chapter 4. Clinical Decision Support Systems Market: Product Estimates & Trend Analysis

  • 4.1. Product Market Share, 2023 & 2030
  • 4.2. Segment Dashboard
  • 4.3. Global Clinical Decision Support Systems Market by Product Outlook
  • 4.4. Standalone CDSS
    • 4.4.1. Market estimates and forecast, 2018 to 2030 (USD Million)
  • 4.5. Integrated CPOE with CDSS
    • 4.5.1. Market estimates and forecast, 2018 to 2030 (USD Million)
  • 4.6. Integrated EHR with CDSS
    • 4.6.1. Market estimates and forecast, 2018 to 2030 (USD Million)
  • 4.7. Integrated CDSS with CPOE and HER
    • 4.7.1. Market estimates and forecast, 2018 to 2030 (USD Million)

Chapter 5. Clinical Decision Support Systems Market: Application Estimates & Trend Analysis

  • 5.1. Application Market Share, 2023 & 2030
  • 5.2. Segment Dashboard
  • 5.3. Global Clinical Decision Support Systems Market, by Application Outlook
  • 5.4. Drug-Drug Interactions
    • 5.4.1. Market estimates and forecast, 2018 to 2030 (USD Million)
  • 5.5. Drug Allergy Alerts
    • 5.5.1. Market estimates and forecast, 2018 to 2030 (USD Million)
  • 5.6. Clinical Reminders
    • 5.6.1. Market estimates and forecast, 2018 to 2030 (USD Million)
  • 5.7. Clinical Guidelines
    • 5.7.1. Market estimates and forecast, 2018 to 2030 (USD Million)
  • 5.8. Drug Dosing Support
    • 5.8.1. Market estimates and forecast, 2018 to 2030 (USD Million)
  • 5.9. Others
    • 5.9.1. Market estimates and forecast, 2018 to 2030 (USD Million)

Chapter 6. Clinical Decision Support Systems Market: Delivery Mode Estimates & Trend Analysis

  • 6.1. Delivery Modes Market Share, 2023 & 2030
  • 6.2. Segment Dashboard
  • 6.3. Global Clinical Decision Support Systems Market, by Delivery Modes Outlook
  • 6.4. Web-Based Systems
    • 6.4.1. Market estimates and forecast, 2018 to 2030 (USD Million)
  • 6.5. Cloud-Based Systems
    • 6.5.1. Market estimates and forecast, 2018 to 2030 (USD Million)
  • 6.6. On-Premise Systems
    • 6.6.1. Market estimates and forecast, 2018 to 2030 (USD Million)

Chapter 7. Clinical Decision Support Systems Market: Component Estimates & Trend Analysis

  • 7.1. Component Market Share, 2023 & 2030
  • 7.2. Segment Dashboard
  • 7.3. Global Clinical Decision Support Systems Market, by Component Outlook
  • 7.4. Hardware
    • 7.4.1. Market estimates and forecast, 2018 to 2030 (USD Million)
  • 7.5. Software
    • 7.5.1. Market estimates and forecast, 2018 to 2030 (USD Million)
  • 7.6. Services
    • 7.6.1. Market estimates and forecast, 2018 to 2030 (USD Million)

Chapter 8. Clinical Decision Support Systems Market: Regional Estimates & Trend Analysis, By Type, By Application, By Delivery Mode, By Component

  • 8.1. Regional Market Share Analysis, 2023 & 2030
  • 8.2. Regional Market Dashboard
  • 8.3. Global Regional Market Snapshot
  • 8.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030
  • 8.5. North America
    • 8.5.1. U.S.
      • 8.5.1.1. Key Country Dynamics
      • 8.5.1.2. Regulatory framework/ reimbursement structure
      • 8.5.1.3. Competitive scenario
      • 8.5.1.4. U.S. market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.5.2. Canada
      • 8.5.2.1. Key Country Dynamics
      • 8.5.2.2. Regulatory framework/ reimbursement structure
      • 8.5.2.3. Competitive scenario
      • 8.5.2.4. Canada market estimates and forecasts, 2018 to 2030 (USD Million)
  • 8.6. Europe
    • 8.6.1. UK
      • 8.6.1.1. Key country dynamics
      • 8.6.1.2. Regulatory framework/ reimbursement structure
      • 8.6.1.3. Competitive scenario
      • 8.6.1.4. UK market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.6.2. Germany
      • 8.6.2.1. Key Country Dynamics
      • 8.6.2.2. Regulatory framework/ reimbursement structure
      • 8.6.2.3. Competitive scenario
      • 8.6.2.4. Germany market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.6.3. France
      • 8.6.3.1. Key Country Dynamics
      • 8.6.3.2. Regulatory framework/ reimbursement structure
      • 8.6.3.3. Competitive scenario
      • 8.6.3.4. France market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.6.4. Italy
      • 8.6.4.1. Key Country Dynamics
      • 8.6.4.2. Regulatory framework/ reimbursement structure
      • 8.6.4.3. Competitive scenario
      • 8.6.4.4. Italy market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.6.5. Spain
      • 8.6.5.1. Key Country Dynamics
      • 8.6.5.2. Regulatory framework/ reimbursement structure
      • 8.6.5.3. Competitive scenario
      • 8.6.5.4. Spain market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.6.6. Norway
      • 8.6.6.1. Key country dynamics
      • 8.6.6.2. Regulatory framework/ reimbursement structure
      • 8.6.6.3. Competitive scenario
      • 8.6.6.4. Norway market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.6.7. Sweden
      • 8.6.7.1. Key country dynamics
      • 8.6.7.2. Regulatory framework/ reimbursement structure
      • 8.6.7.3. Competitive scenario
      • 8.6.7.4. Sweden market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.6.8. Denmark
      • 8.6.8.1. Key country dynamics
      • 8.6.8.2. Regulatory framework/ reimbursement structure
      • 8.6.8.3. Competitive scenario
      • 8.6.8.4. Denmark market estimates and forecasts, 2018 to 2030 (USD Million)
  • 8.7. Asia Pacific
    • 8.7.1. Japan
      • 8.7.1.1. Key country dynamics
      • 8.7.1.2. Regulatory framework/ reimbursement structure
      • 8.7.1.3. Competitive scenario
      • 8.7.1.4. Japan market estimates and forecasts,, 2018 to 2030 (USD Million)
    • 8.7.2. China
      • 8.7.2.1. Key Country Dynamics
      • 8.7.2.2. Regulatory framework/ reimbursement structure
      • 8.7.2.3. Competitive scenario
      • 8.7.2.4. China market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.7.3. India
      • 8.7.3.1. Key Country Dynamics
      • 8.7.3.2. Regulatory framework/ reimbursement structure
      • 8.7.3.3. Competitive scenario
      • 8.7.3.4. India market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.7.4. Australia
      • 8.7.4.1. Key Country Dynamics
      • 8.7.4.2. Regulatory framework/ reimbursement structure
      • 8.7.4.3. Competitive scenario
      • 8.7.4.4. Australia market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.7.5. South Korea
      • 8.7.5.1. Key country dynamics
      • 8.7.5.2. Regulatory framework/ reimbursement structure
      • 8.7.5.3. Competitive scenario
      • 8.7.5.4. South Korea market estimates and forecasts,, 2018 to 2030 (USD Million)
    • 8.7.6. Singapore
      • 8.7.6.1. Key country dynamics
      • 8.7.6.2. Regulatory framework/ reimbursement structure
      • 8.7.6.3. Competitive scenario
      • 8.7.6.4. Singapore market estimates and forecasts, 2018 to 2030 (USD Million)
  • 8.8. Latin America
    • 8.8.1. Brazil
      • 8.8.1.1. Key country dynamics
      • 8.8.1.2. Regulatory framework/ reimbursement structure
      • 8.8.1.3. Competitive scenario
      • 8.8.1.4. Brazil market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.8.2. Mexico
      • 8.8.2.1. Key country dynamics
      • 8.8.2.2. Regulatory framework/ reimbursement structure
      • 8.8.2.3. Competitive scenario
      • 8.8.2.4. Mexico market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.8.3. Argentina
      • 8.8.3.1. Key country dynamics
      • 8.8.3.2. Regulatory framework/ reimbursement structure
      • 8.8.3.3. Competitive scenario
      • 8.8.3.4. Argentina market estimates and forecasts, 2018 to 2030 (USD Million)
  • 8.9. MEA
    • 8.9.1. South Africa
      • 8.9.1.1. Key country dynamics
      • 8.9.1.2. Regulatory framework/ reimbursement structure
      • 8.9.1.3. Competitive scenario
      • 8.9.1.4. South Africa market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.9.2. Saudi Arabia
      • 8.9.2.1. Key country dynamics
      • 8.9.2.2. Regulatory framework/ reimbursement structure
      • 8.9.2.3. Competitive scenario
      • 8.9.2.4. Saudi Arabia market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.9.3. UAE
      • 8.9.3.1. Key country dynamics
      • 8.9.3.2. Regulatory framework/ reimbursement structure
      • 8.9.3.3. Competitive scenario
      • 8.9.3.4. UAE market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.9.4. Kuwait
      • 8.9.4.1. Key country dynamics
      • 8.9.4.2. Regulatory framework/ reimbursement structure
      • 8.9.4.3. Competitive scenario
      • 8.9.4.4. Kuwait market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 9.2. Company/Competition Categorization
    • 9.2.1. Innovators
  • 9.3. Vendor Landscape
    • 9.3.1. List of key distributors and channel partners
    • 9.3.2. Key customers
    • 9.3.3. Key company market share analysis, 2023
    • 9.3.4. McKesson Corporation
      • 9.3.4.1. Company overview
      • 9.3.4.2. Financial performance
      • 9.3.4.3. Product benchmarking
      • 9.3.4.4. Strategic initiatives
    • 9.3.5. Oracle (Cerner Corporation)
      • 9.3.5.1. Company overview
      • 9.3.5.2. Financial performance
      • 9.3.5.3. Product benchmarking
      • 9.3.5.4. Strategic initiatives
    • 9.3.6. Siemens Healthineers GmbH
      • 9.3.6.1. Company overview
      • 9.3.6.2. Financial performance
      • 9.3.6.3. Product benchmarking
      • 9.3.6.4. Strategic initiatives
    • 9.3.7. Allscripts Healthcare, LLC
      • 9.3.7.1. Company overview
      • 9.3.7.2. Financial performance
      • 9.3.7.3. Product benchmarking
      • 9.3.7.4. Strategic initiatives
    • 9.3.8. athenahealth, Inc.
      • 9.3.8.1. Company overview
      • 9.3.8.2. Financial performance
      • 9.3.8.3. Product benchmarking
      • 9.3.8.4. Strategic initiatives
    • 9.3.9. NextGen Healthcare Inc.
      • 9.3.9.1. Company overview
      • 9.3.9.2. Financial performance
      • 9.3.9.3. Product benchmarking
      • 9.3.9.4. Strategic initiatives
    • 9.3.10. Koninklijke Philips N.V.
      • 9.3.10.1. Company overview
      • 9.3.10.2. Financial performance
      • 9.3.10.3. Product benchmarking
      • 9.3.10.4. Strategic initiatives
    • 9.3.11. IBM
      • 9.3.11.1. Company overview
      • 9.3.11.2. Financial performance
      • 9.3.11.3. Product benchmarking
      • 9.3.11.4. Strategic initiatives
    • 9.3.12. Agfa-Gevaert Group
      • 9.3.12.1. Company overview
      • 9.3.12.2. Financial performance
      • 9.3.12.3. Product benchmarking
      • 9.3.12.4. Strategic initiatives
    • 9.3.13. Wolters Kluwer N.V.
      • 9.3.13.1. Company overview
      • 9.3.13.2. Financial performance
      • 9.3.13.3. Product benchmarking
      • 9.3.13.4. Strategic initiatives